Skip to main content

Mathew Blackman

Stock Analyst at Stifel Nicolaus

Total Price Targets
11
Stocks Covered
8
Sectors
Healthcare
Most Recent
Apr 24, 2025

Stocks Covered by Mathew Blackman

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
PENPenumbra, Inc.$318.00$325.86-2.4%1Apr 24, 2025
OFIXOrthofix Medical Inc.$24.00$11.92+101.3%2Nov 8, 2024
CERSCerus Corporation$3.00$2.73+9.7%1Oct 17, 2024
DXCMDexCom, Inc.$100.00$61.51+62.6%3Aug 22, 2024
ATECAlphatec Holdings, Inc.$19.00$10.43+82.2%1Jul 11, 2024
TNDMTandem Diabetes Care, Inc.$37.00$19.34+91.3%1Mar 25, 2024
CLPTClearPoint Neuro, Inc.$9.00$11.40-21.1%1Mar 13, 2024
GMEDGlobus Medical, Inc.$61.00$91.62-33.4%1Sep 19, 2023

Recent Activity

  • Apr 24, 2025— Set$318.00price target onPEN(Penumbra, Inc.)
  • Nov 8, 2024— Set$24.00price target onOFIX(Orthofix Medical Inc.)
  • Oct 17, 2024— Set$3.00price target onCERS(Cerus Corporation)
  • Aug 22, 2024— Set$100.00price target onDXCM(DexCom, Inc.)
  • Jul 12, 2024— Set$132.00price target onDXCM(DexCom, Inc.)
  • Jul 11, 2024— Set$19.00price target onATEC(Alphatec Holdings, Inc.)
  • Mar 25, 2024— Set$37.00price target onTNDM(Tandem Diabetes Care, Inc.)
  • Mar 13, 2024— Set$9.00price target onCLPT(ClearPoint Neuro, Inc.)
  • Sep 19, 2023— Set$61.00price target onGMED(Globus Medical, Inc.)
  • Jun 28, 2022— Set$31.00price target onOFIX(Orthofix Medical Inc.)
  • May 3, 2022— Set$32.50price target onDXCM(DexCom, Inc.)

Frequently Asked Questions

Who is Mathew Blackman?

Mathew Blackman is a stock analyst at Stifel Nicolaus covering 8 stocks primarily in Healthcare. They have issued 11 price targets since May 3, 2022.

What stocks does Mathew Blackman cover?

Mathew Blackman currently covers 8 stocks, including DXCM, OFIX, PEN, CERS, ATEC.

What is Mathew Blackman's latest price target?

Mathew Blackman's most recent price target was $318.00 on PEN (Penumbra, Inc.), set on Apr 24, 2025.

What is Mathew Blackman's highest price target?

Mathew Blackman's highest issued price target is $318.00 on PEN, set on Apr 24, 2025.

Coverage based on publicly published price targets. Not investment advice.